Finance

Beta
Lists
SLXN:NASDAQ
Silexion Therapeutics Corp
$4.84
+13.19%
(+0.56) 1D
May 29, 1:52:46 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLXN...
Open
$4.29
High
$5.45
Low
$4.06
Mkt. cap
20.17M
Avg. vol.
1.17M
Volume
237.68K
52-wk high
$223.60
52-wk low
$2.31
EPS
-$9.45
Beta
-0.28
Shares outstanding
4.19M
No. of employees
14
Open
$4.29
High
$5.45
Low
$4.06
Mkt. cap
20.17M
Avg. vol.
1.17M
Volume
237.68K
52-wk high
$223.60
52-wk low
$2.31
EPS
-$9.45
Beta
-0.28
Shares outstanding
4.19M
No. of employees
14
News stories
From sources across the web
About Silexion Therapeutics Corp
CEO-
Employees14
Founded2008
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
2.16M
3.38M
1.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1.14M
1.03M
1.38M
Operating expense
-
3.29M
4.41M
2.75M
Total operating expenses
-
3.29M
4.41M
2.75M
Operating income
-
-3.29M
-4.41M
-2.75M
Other non operating income
-
23.00K
-35.00K
11.00K
EBT including unusual items
-
-3.26M
-4.41M
-2.73M
EBT excluding unusual items
-
-3.26M
-4.41M
-2.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-3.26M
-4.41M
-2.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
39.00K
69.00K
32.00K
Interest expense
-
-
-
-
Net interest expenses
-
39.00K
69.00K
32.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-3.29M
-4.40M
-2.75M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more